Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Utrecht, The Netherlands, June 17, 2013 - Merus B.V., a biopharmaceutical company focusing on innovative human antibody therapeutics, has presented preclinical data on its antibody MCLA-117 at the Annual 18th Congress of the EHA 2013 in Stockholm.
http://www.biospace.com/news_story.aspx?StoryID=300164&full=1
http://www.biospace.com/news_story.aspx?StoryID=300164&full=1
No comments:
Post a Comment